Mildly oxidized low density lipoprotein (minimally modified low density lipoprotein [MM-LDL]) is capable of inducing gene expression in cells of the artery wall. In this study, we investigated the mechanisms that control the mRNA expression of JE, KC, c-myc, and c-fos in quiescent mouse L-cell fibroblasts stimulated with MM-LDL. The data demonstrate that MM-LDL induces increases 2:20-fold in the levels of transcripts of these genes within 15-60 minutes. Of the four genes examined, JE and KC mRNA showed the greatest response to MM-LDL. The pattern of induction by MM-LDL is distinct from that observed in fibroblasts stimulated with serum, a known inducer of these genes. Treatment with cycloherimide (10 /igjml) did not block the MM-LDL-induced increase in the mRNA levels of these genes. The increase of JE and KC mRNA levels in response to MM-LDL could be blocked by treatment with actinomycin D (5 /ig/ml). In nuclear runoff studies, MM-LDL increased the transcription rate of JE and KC at 4 hours by 13-fold and fivefold, respectively. Small but reproducible stimulations of c-fos and c-myc transcription by MM-LDL were also observed. In addition, the half-life of JE mRNA was increased after addition of MM-LDL to fibroblasts, suggesting that the MM-LDL-induced accumulation of these mRNAs might be accomplished by both transcriptional and posttranscriptional mechanisms. In protein kinase C-depleted fibroblasts, MM-LDL increased JE and KC mRNA levels, whereas the stimulatory effect of 12-O-tetradecanoyl phorbol-13-acetate on JE and KC expression was blocked under these conditions. Taken together, these data demonstrate that MM-LDL increases transcription of the JE and KC genes by a mechanism that does not require de novo protein synthesis and is not mediated via a 12-O-tetradecanoyl phorbol-13 -acetate-responsive protein kinase C pathway. These results provide a basis for further investigations of the molecular mechanism of action of MM-LDL. ( native LDL, is recognized by the LDL receptor but not by the scavenger receptor.
O xidized lipoproteins have been proposed to
produce, in cells of the artery wall, an inflammatory response that is thought to contribute to the early stages of atherosclerosis. Recently, a mildly oxidized form of low density lipoprotein (minimally modified low density lipoprotein [MM-LDL]) 1 has been produced in vitro either by storage at 4°C or by mild iron oxidation. 1 Unlike highly oxidized LDL (>10 nmol thiobarbituric acid-reactive substances [TBARS]/mg cholesterol), MM-LDL shows only minimal oxidation (2-5 nmol TBARS/mg cholesterol). MM-LDL, like native LDL, is recognized by the LDL receptor but not by the scavenger receptor. 1 Treatment of endothelial cells with MM-LDL but not with native LDL resulted in the increased expression of several colony-stimulating factors. 2 In addition, MM-LDL-treated endothelial or smooth muscle cells produced a dose-dependent increase in mRNA levels for monocyte chemotactic protein (MCP-1). 3 Moreover, MM-LDL has been shown to be active in vivo as well as in vitro. 4 All of these findings are consistent with a role for MM-LDL in the accumulation of monocytes/macrophages in the arterial subendothelial space, an important early event in atherogenesis. 5 Recently, MCP-1 was shown to be the human homologue of the mouse JE gene product. 6 " 8 JE gene expression was first described in quiescent mouse fibroblasts stimulated with platelet-derived growth factor (PDGF). 910 Other PDGF-or serum-inducible genes,
including KC, 11 -12 c-fos, 13 -15 and c-myc, 16 ' 17 have been identified. Collectively, these genes have been termed "immediate early response" or "competence" genes. 18 The studies described herein demonstrate that a modified lipoprotein, MM-LDL, is also capable of inducing the expression of the competence gene mRNAs in murine fibroblasts. We have therefore used mouse L-cell fibroblasts as a model system to investigate the mechanisms controlling the expression of competence gene mRNAs in MM-LDL-treated cells. We show that fibroblasts stimulated with MM-LDL demonstrate a pattern of induction distinct from that observed in cells treated with serum, suggesting that these two inducers might use different signaling pathways. Cotreatment of cells with MM-LDL and cycloheximide did not inhibit the MM-LDL-induced accumulation of competence gene mRNAs, demonstrating that MM-LDL acts directly and not via cytokine induction. Furthermore, we show that the MM-LDL-induced increase in JE and KC mRNA levels is in part transcriptional. We also demonstrate that the signaling pathway used by MM-LDL does not involve a 12-O-tetradecanoyl phorbol-13-acetate (TPA)-responsive protein kinase C. However, this pathway can be regulated, as pretreatment of cells with MM-LDL blocks MM-LDLmediated gene induction. Studies are currently underway to identify specific sequences in the promoters of MM-LDL-inducible genes in an attempt to better define the nature of the signaling pathway that is activated by MM-LDL.
Methods

Materials
32
P-labeled cr-deoxycytidine triphosphate and Biotrans nylon membranes were obtained from ICN Pharmaceuticals, Costa Mesa, Calif. TPA, cycloheximide, and actinomycin D were purchased from Sigma Chemical Co., St. Louis, Mo. MM-LDL was prepared by prolonged storage of purified LDL at 4°C in the presence of 0.01% EDTA, 0.15 M NaCl, and 0.01 M Na 2 HPO 4 , pH 7.4, for 4-10 months as previously described.
14 The MM-LDL contained 4 pg lipoporysaccharide (LPS)/^ig LDL protein and <5 nmol TBARS/mg cholesterol, as assayed by previously described methods. 1 JE and KC cDNA probes used in this study were isolated from plasmids pJE 10 and pKC, 9 respectively. These plasmids were purchased from American Type Culture Collection, Rockville, Md. A plasmid containing mouse c-fos cDNA, pfos, was a gift from Dr. R. Chiu (UCLA). The c-myc probe was a mouse genomic insert containing exons 2 and 3 of the c-myc gene 19 and was purchased from the American Type Culture Collection. Human a-tubulin cDNA was a gift from Dr. Winston Salzer (UCLA) and was used as a control, as a-tubulin mRNA levels are unaffected by MM-LDL.
Cell Culture
Mouse L-cell fibroblasts were routinely grown in Dulbecco's modified Eagle's medium (DMEM; GIBCO, Grand Island, N.Y.) supplemented with 10% heat-inactivated fetal calf serum (FCS; Hyclone Laboratories, Logan, Utah) and antibiotics. All experimental procedures were initiated on confluent density-arrested cultures that had been incubated overnight in DMEM supplemented with 0.5% FCS.
Northern Blot Analysis
Total RNA was isolated from mouse L-cell fibroblasts as described. 20 The RNA was electrophoresed through formaldehyde/1% agarose gels and transferred to Biotrans nylon membranes. The blots were hybridized with 32 P-labeled inserts at 55-60°C overnight in a solution containing 0.75 M NaCl, 0.15 M tris(hydroxymethyl)aminomethane HC1 (pH 8.0), 10 mM EDTA, 5x Denhardt's solution ( l x Denhardt's solution is 0.02% bovine serum albumin/0.02% Ficoll/0.02% polyvinylpyrrolidone), 0.1% sodium dodecyl sulfate (SDS), 0.1% sodium pyrophosphate, 100 /xg heat-denatured, sheared, salmon sperm DNA per milliliter, and lxlO 6 cpm of probe (with a specific activity of 2-8x10* cpm//ig DNA insert) per milliliter. Blots were washed twice with 500 ml 2x saline-sodium citrate buffer (SSC; l x SSC is 0.15 M NaCl/15 mM sodium citrate)/0.1% SDS at room temperature for 30 minutes and then washed twice with 0.2-0.5x SSC/0.1% SDS at 55-60°C for 30 minutes. Blots were dried and exposed to Kodak XAR-5 film with an intensifying screen at -70°C.
Nuclear Runoff Transcription Assay
Nuclei were isolated 21 from approximately 5xlO 6 confluent, density-arrested mouse L cells incubated overnight in DMEM supplemented with 0.5% FCS for each time point examined. MM-LDL was added to a final concentration of 10 iiglval, and cells were incubated for 20 minutes, 1 hour, 2 hours, 4 hours, or 24 hours. The zero time point had no addition of MM-LDL. Transcription runoff reactions were performed the same day according to the protocol of Groudine et al. 22 ^-labeled RNA was isolated as described above. 20 Plasmid probes were appropriately digested, and inserts were separated by agarose gel electrophoresis before their transfer to Magna Nt membranes (MSI, Inc.).
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For each time point, equivalent amounts of ^-labeled RNA probe were added to identical Southern blots and hybridized for 3 days at 65°C in the buffer system of deBustros et al. 24 Blots were then washed to a final stringency of 0.1 x SSC/0.1% SDS at 65°C and exposed to HyperfUm MP (Amersham Inc., Arlington Heights, 111.) for 5 or 18 days. For each time point, parallel inductions by MM-LDL were done on separate L-cell cultures, and total RNA was isolated for Northern analysis.
Results
Induction of Competence Gene mRNAs in Quiescent L-Cell Fibroblasts by MM-LDL or Serum
To determine if MM-LDL induces mRNA levels for c-fos, c-myc, JE, and KC, quiescent fibroblasts were treated with MM-LDL (10 Mg/ml), MM-LDL plus cycloheximide (10 Mg/ml)> or cycloheximide alone for 15-240 minutes, and total cellular RNA was analyzed for gene-specific mRNA at various time points by Northern analysis using ^-labeled cDNA or genomic inserts. As shown in Figure 1 , MM-LDL increased the mRNA levels for all four genes. Levels of a-tubulin mRNA were measured as a control to normalize the amount of RNA loaded in each lane. The effect of MM-LDL on c-fos and c-myc mRNA levels was slight and reached a maximum 30-60 minutes after MM-LDL treatment, whereas KC and JE mRNA levels increased greater than 20-fold, with maximum induction occurring 4 hours after MM-LDL stimulation. Furthermore, the ability of MM-LDL to increase the expression of these mRNAs was not inhibited by cycloheximide (Figure 1 ), suggesting that de novo protein synthesis is not required 
FIGURE 1. Northern analysis of competence gene expression in L-cell fibroblasts after treatment with minimally modified low density lipoprotein (MM-LDL) and/or cycloheximide (CHX). MM-LDL (10 fig/ml), MM-LDL plus CHX (10 fig/ml), or CHX alone was added to quiescent L-cell fibroblasts, and total RNA (20 ugllane) was harvested at the time points indicated. Northern blot analysis using 32 P-labeled cDNA inserts was conducted as described in "Methods." The blot was then exposed to Kodak XAR-5 film in a double-sided intensifying screen at -70°C. The far right lane is a positive control containing 20 /jg total RNA isolated from fibroblasts treated with 20% fetal calf serum plus CHX (+S) for 4 hours.
for the induction of the competence genes by MM-LDL in L-cell fibroblasts. As described in other cell types, the basal levels of these mRNAs were increased to varying extents by treatment with cycloheximide alone or serum plus cycloheximide ( Figure I ). 25 *
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Because bacterial LPSs are also known inducers of the competence genes, 27 -28 it was important to rule out LPS contamination of MM-LDL as a possible factor contributing to the mRNA inductions observed in Figure 1. Northern analysis of RNA isolated from fibroblasts stimulated with LPS indicated that 2 ng/ml LPS was required for induction of JE mRNA (data not shown), a concentration well above the levels of LPS contamination detected in MM-LDL (4 pg LPS//*g MM-LDL). Furthermore, native unoxidized LDL did not stimulate the expression of the JE gene (data not shown). Therefore, MM-LDL alone appears sufficient to induce the expression of the competence gene mRNAs.
Expression of the competence genes in quiescent serum-starved fibroblasts has previously been demonstrated to be induced by serum treatment. 25 Therefore, we sought to compare the response of fibroblasts to stimulation with either MM-LDL (Figure 1) or serum. As shown in Figure 2 , serum-starved fibroblasts treated with 20% serum, 20% serum plus cycloheximide (10 /ug/ml), or cycloheximide alone for 15-240 minutes showed a serum-induced increase in mRNA levels independent of protein synthesis. manner, certain temporal and quantitative differences in the response of the competence genes to these two stimuli are detectable. For example, maximum induction of KC mRNA in response to serum stimulation is observed 1 hour after treatment compared with 4 hours after MM-LDL stimulation. Furthermore, the magnitude of induction of the c-fos gene in response to treatment of fibroblasts with either MM-LDL or serum is markedly different; c-fos mRNA levels increased threefold or 35-fold 30 minutes after treatment with MM-LDL or serum, respectively.
MM-LDL Induces JE and KC mRNA Levels via Transcriptional Activation
Because the mRNAs for these genes have been reported to be short lived, with half-lives ranging from minutes (c-fos, c-myc) 25 to hours (JE), 29 it was important to determine if induction of these genes by MM-LDL occurred via enhanced transcription, enhanced stability of the mRNA, or a combination of both mechanisms. One way to gain insight into which of the above mechanisms is involved in the regulation of these transcripts in L-cell fibroblasts is to examine the effect of an inhibitor of transcription, actinomycin D, on the ability of MM-LDL to increase mRNA levels in fibroblasts. Because JE and KC mRNA expression was most responsive to MM-LDL stimulation (Figure 1 ), quiescent fibroblasts stimulated with MM-LDL (10 /ig/ml), MM-LDL plus actinomycin D (5 /ig/ml), or actinomycin D alone were analyzed for levels of JE and KC mRNA by Northern blot analysis. As shown in Figure 3A , the induction of JE and KC mRNA by MM-LDL (lanes 5 and 6) is prevented when fibroblasts are stimulated by MM-LDL in the presence of actinomycin D (lanes 7 and 8) .
JE mRNA Is Stabilized in MM-LDL-Treated Fibroblasts
Experiments were also conducted to determine the effect of MM-LDL on the stability of JE and KC mRNAs. The rate of decay of JE and KC mRNA in control and MM-LDL-treated fibroblasts was determined after inhibition of transcription with actinomycin D (5 Mg/ml)-As shown in Figure 3B , the half-life of JE mRNA in control quiescent fibroblasts was 2 hours, whereas the levels of JE mRNA in MM-LDL-stimulated fibroblasts remained steady throughout the 4-hour incubation with actinomycin D. The levels of KC mRNA in MM-LDL-stimulated cells also did not change during 4 hours of treatment with actinomycin D (data not shown). However, it was not possible to determine the half-life of KC mRNA in cells not treated with MM-LDL, as the RNA levels were too low to quantify accurately.
Effect of MM-LDL on the Transcription Rates of the Competence Genes
To confirm that MM-LDL induces transcription of the JE and KC genes, nuclear runoff analysis was conducted. Nuclei from control and MM-LDL-treated fibroblasts were harvested at various time points after treatment, and the relative amount of nascent mRNA was quantified by nuclear runoff transcription ( Figure  4 ). Levels of a-tubulin mRNA were measured as a control to confirm that equal amounts of labeled mRNA were used at each time point. As shown in Figures 4A  and 4B , MM-LDL stimulation produced an increase in the transcription of the KC and JE genes by 20 and 60 minutes, respectively, and was maximal at 4 hours (fivefold and 13-fold, respectively). By contrast, the effect of MM-LDL on c-fos transcription was slight, with a maximum increase of twofold observed at 20 minutes. Transcription of c-myc increased gradually, reaching a maximum fourfold increase at 24 hours (Figures 4A and  4B ). For comparison, levels of JE and KC mRNAs in MM-LDL-stimulated fibroblasts were determined by Northern blotting. Quantification of the autoradiographs of the nuclear runoff and the Northern analyses demonstrates that the increase in the relative transcription rate of JE induced by MM-LDL is similar to the magnitude of its effect on JE mRNA levels observed in Northern blot experiments ( Figure 4C ). By contrast, the increase in the transcription rate of KC observed in MM-LDL-stimulated fibroblasts accounts for only part of the effect of MM-LDL on KC mRNA levels observed in Northern blot experiments ( Figure 4C ), suggesting that MM-LDL-induced gene expression is controlled at both the transcriptional and posttranscriptional levels.
Induction of JE and KC mRNAs by MM-LDL Is Not Mediated by a TPA-Dependent Protein Kinase C Pathway
Preliminary experiments also demonstrated an induction of JE and KC mRNAs in quiescent L cells stimulated with TPA for 3 hours. Because TPA is an efficient activator of protein kinase C, we sought to determine whether MM-LDL stimulated JE and KC mRNA levels via a TPA-responsive protein kinase C pathway. In brief, fibroblasts incubated overnight in DMEM plus 0.5% serum were treated for an additional 24 hours with DMEM plus 0.5% serum in the absence or presence of TPA (50 ng/ml). The latter treatment is known to result in inactivation of protein kinase C.
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- 31 After these 48-hour treatments, cells were stimulated with either TPA (50 ng/ml) or MM-LDL (10 /ig/ml) for 3 or 4 hours, respectively, before harvesting of total RNA. As shown in Figure 5 (lanes 3-6) , incubation of quiescent cells with either TPA or MM-LDL resulted in increased levels of JE and KC mRNA. As expected, the stimulation of JE and KC mRNA levels by TPA was not observed in cells that had been pretreated for 24 hours with TPA ( Figure 5 ; compare lanes 7 and 8 with lanes 9 and 10). In contrast to these latter results, MM-LDL was able to stimulate the mRNA levels of JE and KC even in cells pretreated for 24 hours with TPA ( Figure  5 ; compare lanes 7 and 8 with lanes 11 and 12).
MM-LDL Induction of JE and KC mRNAs Is Blocked by MM-LDL Pretreatment
Studies of endothelial cells have shown that continuous exposure of cells to MM-LDL can result in loss of responsiveness to MM-LDL, as determined by decreased monocyte binding. 1 These results suggested that MM-LDL pretreatment might convert MM-LDL-sensitive cells into resistant cells. Therefore, we conducted an experiment to determine whether MM-LDL pretreatment of fibroblasts could block the ability of MM-LDL to induce the expression of JE and KC. Fibroblasts incubated overnight in DMEM plus 0.5% serum were incubated for an additional 24 hours in the same 2) . Taken together, these data suggest that MM-LDL induction of these genes does not occur through a TPA-responsive protein kinase C pathway.
Discussion
The effect of MM-LDL on competence gene mRNAs was examined in quiescent fibroblasts cultured under conditions of serum starvation. By using serum-starved fibroblasts, we minimized the possibility that a serum factor might be required for MM-LDL to exert an effect. In addition, because competence gene expression could be induced in quiescent fibroblasts treated with serum, we were able to compare the response of fibroblasts to either MM-LDL or serum. The results demonstrate that the pattern of gene induction by MM-LDL is distinct from that observed in fibroblasts stimulated with serum (compare Figures 1 and 2) . Furthermore, the data show that MM-LDL treatment of quiescent mouse fibroblasts results in increased mRNA levels of the competence genes within 15-60 minutes by a mechanism that does not require de novo protein synthesis.
Of the four genes examined in this study, JE and KC showed the greatest responsiveness to MM-LDL. A marked increase in the transcription rate of KC and JE was observed within 20-60 minutes after MM-LDL treatment. However, the observed stabilization of JE mRNA, in response to MM-LDL treatment ( Figure  3B ), suggests that MM-LDL induction of JE and KC mRNAs may also occur in part at the posttranscriptional level. Indeed, both JE and KC mRNAs contain AU-rich sequences in their 3'-untranslated regions. These AU-rich sequences are believed to play a role in the mRNA turnover of a number of short-lived mRNAs.
-53
The intracellular pathway(s) by which MM-LDL induces gene expression remain(s) unknown. The data demonstrate that the mechanism of induction of JE and KC mRNA by MM-LDL is not mediated via a TPAresponsive protein kinase C pathway (Figures 5 and 6 ). By comparison, pretreatment of cells with MM-LDL rendered the cells resistant to subsequent stimulation by MM-LDL, suggesting that the signaling pathway used by MM-LDL can be regulated. In addition, it should be noted that the observed stimulation of JE and KC genes by TPA (Figures 5 and 6 ) differs from that in a previous report, 34 in which little or no response of JE and KC mRNA to TPA treatment of BALB/C-3T3 cells was observed. The discrepancy between the results is unknown but conceivably may be due to subtle differences in the cell lines used.
The ability of MM-LDL to induce the mRNAs for JE and KC suggests a potential role for their gene products 35 In these studies, malignant cells engineered to express either JE or MCP-1 were injected into nude mice. These mice subsequently exhibited a monocytic infiltration at the site of injection and an inability to form tumors. MCP-1 expression has also been shown to account for all of the monocyte chemotactic activity produced by endothelial and smooth muscle cells stimulated with MM-LDL. 3 In addition, MCP-1 expression has been detected in macrophage-rich areas of rabbit and human atherosclerotic lesions but not in normal arteries. 36 Thus MM-LDL, if present in the artery wall, might be expected to cause the release of JE/MCP-1 and to promote recruitment of monocytes into the subendothelial space. The existence of modified LDL in vivo in the artery wall has indeed been demonstrated, 37 ' 38 and monocytic recruitment into the artery wall is observed in animals susceptible to atherosclerosis as well as after ingestion of a fat-rich diet. 39 Thus, JE/MCP-1 may play an important early role in atherosclerosis. In contrast to JE/MCP-1, a function has not been definitively assigned to the protein encoded by the KC gene. Comparison of cDNA sequences has shown that KC is identical to the melanoma growth stimulating activity (MGSA), a protein secreted by human melanoma cells. 40 MGSA (now also called gro) is, in turn, the human homologue of the gro gene, a constitutively expressed protein originally identified in Chinese hamster ovary cells. 41 Recently, Kawahara and Deuel 42 have pointed out that KC/MGSA/gro and JE/MCP-1 are members of a family of related inducible cytokines that are either mitogenic or chemotactic. These genes, termed small inducible genes, are believed to act as intercellular mediators of responses designed to combat infection and promote wound healing. Therefore, the ability of MM-LDL to dramatically induce the mRNA expression of either KC/MGSA/gro or JE/MCP-1 in cells of the artery wall suggests yet another physiological context in which these cytokines might play a role, namely in the early development of lesions in atherogenesis.
